Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2016

Mar 3, 2016

29777_dirs_2016-03-02_f0128126-48e8-423c-aa77-716ea0658b2e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-02-29

Reporting Person: YOOR BRIAN B (Senior Vice President and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-29 Common shares without par value F 1840 $39.52 Disposed 52250 Direct
2016-02-29 Common shares without par value S 165 $39.1223 Disposed 52085 Direct
2016-02-29 Common shares without par value S 700 $39.125 Disposed 51385 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 2078 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 29, 2016.